firstpost_date,url,trackback_author_nick,content,score,trackback_permalink,trackback_author_url
06/02/14,http://twitter.com/drmiguelperales/status/473261580839575552,drmiguelperales,In #BBMT MT @plmcc54 RPCI allogeneic HSCT approach to very high risk relapsed/refractory AML. http://t.co/isP5kV64qa … #bmtsm #leusm,6.935789,http://twitter.com/DrMiguelPerales/status/473261580839575552,http://twitter.com/drmiguelperales
06/03/14,http://twitter.com/mtmdphd/status/473797412310773760,mtmdphd,@TapKadia We missed your #leusm tweets. Hope to see you at #ASH14 also,11.058224,http://twitter.com/mtmdphd/status/473797412310773760,http://twitter.com/mtmdphd
06/04/14,http://twitter.com/drmiguelperales/status/474191943346700288,drmiguelperales,Stem Cell Transplant Clinical trials @sloan_kettering http://t.co/9gme4uYCxQ  http://t.co/UO5s7X5lkw  #bmtsm #mmsm #leusm #lymsm,8.897245,http://twitter.com/DrMiguelPerales/status/474191943346700288,http://twitter.com/drmiguelperales
06/04/14,http://twitter.com/natedahlpharmd/status/474198410757558272,natedahlpharmd,RT @DrMiguelPerales: Stem Cell Transplant Clinical trials @sloan_kettering http://t.co/9gme4uYCxQ  http://t.co/UO5s7X5lkw  #bmtsm #mmsm #le…,7.170387,http://twitter.com/NateDahlPharmD/status/474198410757558272,http://twitter.com/natedahlpharmd
06/05/14,http://twitter.com/asbmt/status/474585247112130561,asbmt,Open to enrollment: #BMTCTN 1102 MDS RIC transplant vs. supportive care (biol. assigmt.) for older pts http://t.co/rKQhIwsg1a #bmtsm #leusm,9.725708,http://twitter.com/ASBMT/status/474585247112130561,http://twitter.com/asbmt
06/05/14,http://twitter.com/alindfole/status/474585402150367232,alindfole,RT @ASBMT: Open to enrollment: #BMTCTN 1102 MDS RIC transplant vs. supportive care (biol. assigmt.) for older pts http://t.co/rKQhIwsg1a #b…,6.9019194,http://twitter.com/alindfole/status/474585402150367232,http://twitter.com/alindfole
06/05/14,http://twitter.com/subatomicdoc/status/474604136076693504,subatomicdoc,Clarissa helps teens ride the cancer coaster http://t.co/AihhjQVdXf &gt; @Paulflevy #ayacsm #leusm,10.9987135,http://twitter.com/subatomicdoc/status/474604136076693504,http://twitter.com/subatomicdoc
06/05/14,http://twitter.com/natedahlpharmd/status/474653189271060480,natedahlpharmd,New Combinations With #Rituximab Demonstrate Efficacy in #CLL http://t.co/0B5J97zSwg via @TargetedOnc #leusm #hematology,7.392565,http://twitter.com/NateDahlPharmD/status/474653189271060480,http://twitter.com/natedahlpharmd
06/06/14,http://twitter.com/lemaistrefred/status/474712580963835904,lemaistrefred,RT @ASBMT: Open to enrollment: #BMTCTN 1102 MDS RIC transplant vs. supportive care (biol. assigmt.) for older pts http://t.co/rKQhIwsg1a #b…,6.9019194,http://twitter.com/LemaistreFred/status/474712580963835904,http://twitter.com/lemaistrefred
06/06/14,http://twitter.com/drmiguelperales/status/474935785796288512,drmiguelperales,#cordbloodsymp14 @cityofhope proposal for management of leukemia care and transplant #bmtsm #leusm http://t.co/AowBbmu3rF,8.334508,http://twitter.com/DrMiguelPerales/status/474935785796288512,http://twitter.com/drmiguelperales
06/06/14,http://twitter.com/drzafergokgoz/status/474938379218735104,drzafergokgoz,RT @DrMiguelPerales: #cordbloodsymp14 @cityofhope proposal for management of leukemia care and transplant #bmtsm #leusm http://t.co/AowBbmu…,7.242827,http://twitter.com/drzafergokgoz/status/474938379218735104,http://twitter.com/drzafergokgoz
06/07/14,http://twitter.com/drmiguelperales/status/475304966710509568,drmiguelperales,#cordbloodsymp14 Michael Pulsipher fr @huntsmancancer presenting data on MRD after transplant for pediatric ALL #leusm #bmtsm,7.1197634,http://twitter.com/DrMiguelPerales/status/475304966710509568,http://twitter.com/drmiguelperales
06/07/14,http://twitter.com/drmiguelperales/status/475311270745219072,drmiguelperales,#CordBloodSymp14 Efficacy and toxicity management of CAR T cells ALL. Davila #scitranslmed 2014 http://t.co/oH1CPCqIky #leusm,7.324756,http://twitter.com/DrMiguelPerales/status/475311270745219072,http://twitter.com/drmiguelperales
06/07/14,http://twitter.com/fischmd/status/475417797678608384,fischmd,"Durable control of #bloodcancer is most critical to improve the overall outcome of pts with incr 
#comorbidity http://t.co/UPbqdKtLL2 #leusm",10.680059,http://twitter.com/fischmd/status/475417797678608384,http://twitter.com/fischmd
06/09/14,http://twitter.com/bmtjolene/status/476015958641766400,bmtjolene,Quick $PCYC move: sNDA for full approval filed today; Imbruvica rec'd accelerated approval in CLL 2/2014 (MCL 11/2013) #leusm #CLL,9.586305,http://twitter.com/BMTJolene/status/476015958641766400,http://twitter.com/bmtjolene
06/09/14,http://twitter.com/bmtrobert/status/476019559674433537,bmtrobert,RT @BMTJolene: Quick $PCYC move: sNDA for full approval filed today; Imbruvica rec'd accelerated approval in CLL 2/2014 (MCL 11/2013) #leus…,7.016043,http://twitter.com/BMTRobert/status/476019559674433537,http://twitter.com/bmtrobert
06/09/14,http://twitter.com/yuzhu4/status/476088277384978432,yuzhu4,RT @BMTJolene: Quick $PCYC move: sNDA for full approval filed today; Imbruvica rec'd accelerated approval in CLL 2/2014 (MCL 11/2013) #leus…,7.016043,http://twitter.com/YuZhu4/status/476088277384978432,http://twitter.com/yuzhu4
06/10/14,http://twitter.com/transplant_doc/status/476363354412298241,transplant_doc,RT @ASBMT: Open to enrollment: #BMTCTN 1102 MDS RIC transplant vs. supportive care (biol. assigmt.) for older pts http://t.co/rKQhIwsg1a #b…,6.9019194,http://twitter.com/Transplant_Doc/status/476363354412298241,http://twitter.com/transplant_doc
06/10/14,http://twitter.com/drmiguelperales/status/476364208787841025,drmiguelperales,RT @ASBMT: Open to enrollment: #BMTCTN 1102 MDS RIC transplant vs. supportive care (biol. assigmt.) for older pts http://t.co/rKQhIwsg1a #b…,6.9019194,http://twitter.com/DrMiguelPerales/status/476364208787841025,http://twitter.com/drmiguelperales
06/10/14,http://twitter.com/datamonitor_ea/status/476435838931599361,datamonitor_ea,RT @BMTJolene: Quick $PCYC move: sNDA for full approval filed today; Imbruvica rec'd accelerated approval in CLL 2/2014 (MCL 11/2013) #leus…,7.016043,http://twitter.com/Datamonitor_EA/status/476435838931599361,http://twitter.com/datamonitor_ea
06/11/14,http://twitter.com/danafarber/status/476833760248606720,danafarber,Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,13.478898,http://twitter.com/DanaFarber/status/476833760248606720,http://twitter.com/danafarber
06/11/14,http://twitter.com/drbachinsky/status/476834882711453696,drbachinsky,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,7.6442122,http://twitter.com/drbachinsky/status/476834882711453696,http://twitter.com/drbachinsky
06/11/14,http://twitter.com/louisjdegennaro/status/476835667557629952,louisjdegennaro,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,7.6442122,http://twitter.com/LouisJDeGennaro/status/476835667557629952,http://twitter.com/louisjdegennaro
06/11/14,http://twitter.com/cancernetwrk/status/476835814346067969,cancernetwrk,RT @DanaFarber View translation Down syndrome-leukemia link identified: http://t.co/mEfWcuLvlx  #leusm,10.758321,http://twitter.com/CancerNetwrk/status/476835814346067969,http://twitter.com/cancernetwrk
06/11/14,http://twitter.com/llsntx/status/476836878960717824,llsntx,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,7.6442122,http://twitter.com/llsntx/status/476836878960717824,http://twitter.com/llsntx
06/11/14,http://twitter.com/friendsofkaren/status/476837137758031872,friendsofkaren,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,7.6442122,http://twitter.com/FriendsofKaren/status/476837137758031872,http://twitter.com/friendsofkaren
06/11/14,http://twitter.com/vscooper/status/476852397760057346,vscooper,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,7.6442122,http://twitter.com/vscooper/status/476852397760057346,http://twitter.com/vscooper
06/11/14,http://twitter.com/dawnka/status/476860245101129729,dawnka,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,10.864755,http://twitter.com/DawnKA/status/476860245101129729,http://twitter.com/dawnka
06/11/14,http://twitter.com/timtimoredwarf/status/476862699188785153,timtimoredwarf,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,7.6442122,http://twitter.com/TimTimoredwarf/status/476862699188785153,http://twitter.com/timtimoredwarf
06/12/14,http://twitter.com/nicolebelllls/status/476897066174521344,nicolebelllls,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/xzfwx67gUk #leusm,7.6442122,http://twitter.com/NicoleBellLLS/status/476897066174521344,http://twitter.com/nicolebelllls
06/12/14,http://twitter.com/catalyticrxn/status/477105563524800513,catalyticrxn,RT @DanaFarber: Down syndrome-leukemia link identified: http://t.co/ddzwfa0z2I #leusm,7.717576,http://twitter.com/CatalyticRxn/status/477105563524800513,http://twitter.com/catalyticrxn
06/13/14,http://twitter.com/doctorpemm/status/477281243298410496,doctorpemm,Pleural effusions in acute myeloid leukemia -report and review #AML #leukemia #leusm http://t.co/FzRWaVg9hq #ExtramedullaryAML,7.2210746,http://twitter.com/doctorpemm/status/477281243298410496,http://twitter.com/doctorpemm
06/13/14,http://twitter.com/tapkadia/status/477403171606638592,tapkadia,#eha19 - Sitting at Opening Presidential session at EHA meeting in Milan - Impressive show. #leukemia #leusm #hematology,7.0702286,http://twitter.com/TapKadia/status/477403171606638592,http://twitter.com/tapkadia
06/13/14,http://twitter.com/tapkadia/status/477425014568804352,tapkadia,#eha19 - Opera singing hematologist entertaining us at the European Hematology Assoc Congress #leusm http://t.co/rnszJw5Er5,7.3643703,http://twitter.com/TapKadia/status/477425014568804352,http://twitter.com/tapkadia
06/13/14,http://twitter.com/tapkadia/status/477425835293806592,tapkadia,#eha19 Hartmut Dohner being honored with Jose Carreras Award at the EHA annual congress for his work mutations in #AML #leusm,9.198043,http://twitter.com/TapKadia/status/477425835293806592,http://twitter.com/tapkadia
06/13/14,http://twitter.com/tapkadia/status/477425973819113473,tapkadia,#eha19 Dohner: we must recognize the tremendous heterogeneity in #AML. #leusm,8.407984,http://twitter.com/TapKadia/status/477425973819113473,http://twitter.com/tapkadia
06/13/14,http://twitter.com/tapkadia/status/477426717641170944,tapkadia,#eha19 Dohner : AML genomes have fewer mutations than almost any other human cancer. #leusm,7.42366,http://twitter.com/TapKadia/status/477426717641170944,http://twitter.com/tapkadia
06/13/14,http://twitter.com/tapkadia/status/477430847499694080,tapkadia,"#eha19 PLK1 highly expressed in #AML, and not in non-dividing cells. Volasertib + LDAC shows poss OS benefit compared to LDAC alone. #leusm",8.472245,http://twitter.com/TapKadia/status/477430847499694080,http://twitter.com/tapkadia
06/13/14,http://twitter.com/tapkadia/status/477431369707315200,tapkadia,#AML with RUNX1 - A New Entity? #eha19 #leusm http://t.co/IFJciGnf2X,8.866746,http://twitter.com/TapKadia/status/477431369707315200,http://twitter.com/tapkadia
06/13/14,http://twitter.com/tapkadia/status/477432030993842176,tapkadia,"#eha19 Targeted Therapy in #AML #leusm cc: @leukemiamda, @garciamanero",8.454441,http://twitter.com/TapKadia/status/477432030993842176,http://twitter.com/tapkadia
06/13/14,http://twitter.com/tapkadia/status/477432183259660288,tapkadia,"@TapKadia: #eha19 Targeted Therapy in #AML #leusm cc: @leukemiamda, @garciamanero http://t.co/cAPbsEZxRK",8.086191,http://twitter.com/TapKadia/status/477432183259660288,http://twitter.com/tapkadia
06/13/14,http://twitter.com/leukemiamda/status/477438760024432640,leukemiamda,"RT @TapKadia: @TapKadia: #eha19 Targeted Therapy in #AML #leusm cc: @leukemiamda, @garciamanero http://t.co/cAPbsEZxRK",7.053645,http://twitter.com/leukemiamda/status/477438760024432640,http://twitter.com/leukemiamda
06/13/14,http://twitter.com/prime_oncology/status/477449051042893824,prime_oncology,RT @TapKadia: #eha19 Hartmut Dohner being honored with Jose Carreras Award at the EHA annual congress for his work mutations in #AML #leusm,6.931777,http://twitter.com/prIME_Oncology/status/477449051042893824,http://twitter.com/prime_oncology
06/13/14,http://twitter.com/leukemiamda/status/477452962969550849,leukemiamda,RT @TapKadia: #eha19 Hartmut Dohner being honored with Jose Carreras Award at the EHA annual congress for his work mutations in #AML #leusm,6.931777,http://twitter.com/leukemiamda/status/477452962969550849,http://twitter.com/leukemiamda
06/13/14,http://twitter.com/prime_oncology/status/477477048177266688,prime_oncology,"RT @TapKadia: #eha19 PLK1 highly expressed in #AML, and not in non-dividing cells. Volasertib + LDAC shows poss OS benefit compared to LDAC…",6.7186875,http://twitter.com/prIME_Oncology/status/477477048177266688,http://twitter.com/prime_oncology
06/14/14,http://twitter.com/doctorpemm/status/477617031521378304,doctorpemm,RT @TapKadia: #eha19 Dohner: we must recognize the tremendous heterogeneity in #AML. #leusm,7.342188,http://twitter.com/doctorpemm/status/477617031521378304,http://twitter.com/doctorpemm
06/14/14,http://twitter.com/prime_oncology/status/477796145490825216,prime_oncology,RT @TapKadia: #AML with RUNX1 - A New Entity? #eha19 #leusm http://t.co/IFJciGnf2X,7.11804,http://twitter.com/prIME_Oncology/status/477796145490825216,http://twitter.com/prime_oncology
06/16/14,http://twitter.com/patientpower/status/478643227017637888,patientpower,A chance encounter with another CLL patient led Alan Holtzman to a leading specialist. Learn his story. #cll #leusm http://t.co/LYFiCesMXZ,8.270683,http://twitter.com/PatientPower/status/478643227017637888,http://twitter.com/patientpower
06/17/14,http://twitter.com/sherylmcintire/status/478715937458122752,sherylmcintire,RT @PatientPower: A chance encounter with another CLL patient led Alan Holtzman to a leading specialist. Learn his story. #cll #leusm http:…,7.284412,http://twitter.com/SherylMcIntire/status/478715937458122752,http://twitter.com/sherylmcintire
06/18/14,http://twitter.com/doctorpemm/status/479104211473272832,doctorpemm,CML is not only a cancer of older adults-it affects adolescents and young adults too #ayacancer #ayacsm #AYA #leusm http://t.co/fJVgwmrjCm,10.998793,http://twitter.com/doctorpemm/status/479104211473272832,http://twitter.com/doctorpemm
06/18/14,http://twitter.com/hayeslat/status/479110942425243648,hayeslat,RT @doctorpemm: CML is not only a cancer of older adults-it affects adolescents and young adults too #ayacancer #ayacsm #AYA #leusm http://…,10.170898,http://twitter.com/hayeslat/status/479110942425243648,http://twitter.com/hayeslat
06/19/14,http://twitter.com/mtmdphd/status/479721024041525249,mtmdphd,Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in CML -  Herrmann et al. Blood http://t.co/GXS2aVst1R #leusm,10.985372,http://twitter.com/mtmdphd/status/479721024041525249,http://twitter.com/mtmdphd
06/19/14,http://twitter.com/drzafergokgoz/status/479721910486708225,drzafergokgoz,RT @mtmdphd: Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in CML -  Herrmann et al. Blood http://t.co/GXS2aVst1R #leusm,6.9923887,http://twitter.com/drzafergokgoz/status/479721910486708225,http://twitter.com/drzafergokgoz
06/19/14,http://twitter.com/mtmdphd/status/479723124305690624,mtmdphd,CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders - 2007 http://t.co/4J9a5tSBAW #leusm,10.191352,http://twitter.com/mtmdphd/status/479723124305690624,http://twitter.com/mtmdphd
06/19/14,http://twitter.com/drmiguelperales/status/479736998198902784,drmiguelperales,Outcomes of adults with acute lymphoblastic #leukemia relapsing after alloHCT #BMTCTN #bmtsm #leusm http://t.co/luBpu5ckr9,7.9691653,http://twitter.com/DrMiguelPerales/status/479736998198902784,http://twitter.com/drmiguelperales
06/20/14,http://twitter.com/nextgen_ltd/status/479818687948791808,nextgen_ltd,RT @DrMiguelPerales: Outcomes of adults with acute lymphoblastic #leukemia relapsing after alloHCT #BMTCTN #bmtsm #leusm http://t.co/luBpu5…,6.981065,http://twitter.com/NextGEN_Ltd/status/479818687948791808,http://twitter.com/nextgen_ltd
06/20/14,http://twitter.com/mdandersonnews/status/480018607603064832,mdandersonnews,Receiving an #AML diagnosis while pregnant: A survivor looks back http://t.co/RhUxU8OpIB #leukemia #leusm #endcancer,12.208033,http://twitter.com/MDAndersonNews/status/480018607603064832,http://twitter.com/mdandersonnews
06/20/14,http://twitter.com/jomaxx/status/480019103625646081,jomaxx,RT @MDAndersonNews: Receiving an #AML diagnosis while pregnant: A survivor looks back http://t.co/RhUxU8OpIB #leukemia #leusm #endcancer,10.858636,http://twitter.com/jomaxx/status/480019103625646081,http://twitter.com/jomaxx
06/20/14,http://twitter.com/suhaghoul/status/480019531105316864,suhaghoul,RT @MDAndersonNews: Receiving an #AML diagnosis while pregnant: A survivor looks back http://t.co/RhUxU8OpIB #leukemia #leusm #endcancer,7.4894185,http://twitter.com/suhaghoul/status/480019531105316864,http://twitter.com/suhaghoul
06/23/14,http://twitter.com/natedahlpharmd/status/481175664125423616,natedahlpharmd,A Phase I Study of the Mitochondrial Metabolism Inhibitor CPI-613 for #AML http://t.co/2eF6TLrMMR via @TargetedOnc #leukemia #leusm,7.3827815,http://twitter.com/NateDahlPharmD/status/481175664125423616,http://twitter.com/natedahlpharmd
06/23/14,http://twitter.com/drmiguelperales/status/481179962784104449,drmiguelperales,Novel integrated cytogenetic + genomic classification refines risk stratification in peds ALL http://t.co/GHhC0zpcTk #Bloodjournal #leusm,8.078937,http://twitter.com/DrMiguelPerales/status/481179962784104449,http://twitter.com/drmiguelperales
06/24/14,http://twitter.com/doctorpemm/status/481266701074321410,doctorpemm,“@leukemiamda: #Inspirational testimonials from our #leukemia patients at Patient Corner: http://t.co/02jgLDyUtv” #leusm #bloodcancers,7.400615,http://twitter.com/doctorpemm/status/481266701074321410,http://twitter.com/doctorpemm
06/24/14,http://twitter.com/nextgen_ltd/status/481282351155384320,nextgen_ltd,RT @DrMiguelPerales: Novel integrated cytogenetic + genomic classification refines risk stratification in peds ALL http://t.co/GHhC0zpcTk #…,7.053645,http://twitter.com/NextGEN_Ltd/status/481282351155384320,http://twitter.com/nextgen_ltd
06/27/14,http://twitter.com/drmiguelperales/status/482316797454974977,drmiguelperales,BBC News - Breast cancer drug hope from leukaemia research - RUNX1 gene may play a role in both #bcsm #leusm http://t.co/SgnLZRbPwe,8.343402,http://twitter.com/DrMiguelPerales/status/482316797454974977,http://twitter.com/drmiguelperales
06/27/14,http://twitter.com/plmcc54/status/482324204511969281,plmcc54,RT @DrMiguelPerales: BBC News - Breast cancer drug hope from leukaemia research - RUNX1 gene may play a role in both #bcsm #leusm http://t.…,6.8964176,http://twitter.com/plmcc54/status/482324204511969281,http://twitter.com/plmcc54
06/27/14,http://twitter.com/emmapettengale/status/482556974991958016,emmapettengale,RT @DrMiguelPerales: BBC News - Breast cancer drug hope from leukaemia research - RUNX1 gene may play a role in both #bcsm #leusm http://t.…,6.8964176,http://twitter.com/EmmaPettengale/status/482556974991958016,http://twitter.com/emmapettengale
